Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $15
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $15.
Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $15.